UA117908C2 - Застосування гепарину або гепарансульфату для індукції пологів - Google Patents
Застосування гепарину або гепарансульфату для індукції пологівInfo
- Publication number
- UA117908C2 UA117908C2 UAA201411546A UAA201411546A UA117908C2 UA 117908 C2 UA117908 C2 UA 117908C2 UA A201411546 A UAA201411546 A UA A201411546A UA A201411546 A UAA201411546 A UA A201411546A UA 117908 C2 UA117908 C2 UA 117908C2
- Authority
- UA
- Ukraine
- Prior art keywords
- combination treatment
- inducing labor
- sulphated glycosaminoglycans
- glycosaminoglycans
- inducing
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 title abstract 3
- 230000001939 inductive effect Effects 0.000 title abstract 2
- 238000011284 combination treatment Methods 0.000 title 1
- 230000001737 promoting effect Effects 0.000 abstract 2
- 238000002648 combination therapy Methods 0.000 abstract 1
- 230000014508 negative regulation of coagulation Effects 0.000 abstract 1
- 230000005070 ripening Effects 0.000 abstract 1
- 230000013948 uterine smooth muscle contraction Effects 0.000 abstract 1
- 210000004291 uterus Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615398P | 2012-03-26 | 2012-03-26 | |
| PCT/SE2013/050332 WO2013147689A1 (en) | 2012-03-26 | 2013-03-25 | Combination treatment comprising sulphated glycosaminoglycans for inducing labor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA117908C2 true UA117908C2 (uk) | 2018-10-25 |
Family
ID=49260783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201411546A UA117908C2 (uk) | 2012-03-26 | 2013-03-25 | Застосування гепарину або гепарансульфату для індукції пологів |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150045322A1 (enExample) |
| EP (1) | EP2830635A4 (enExample) |
| JP (1) | JP6234989B2 (enExample) |
| CN (1) | CN104203256B (enExample) |
| AU (1) | AU2013240597A1 (enExample) |
| CA (1) | CA2868444A1 (enExample) |
| HK (1) | HK1203369A1 (enExample) |
| IL (1) | IL234689A0 (enExample) |
| MX (1) | MX2014011505A (enExample) |
| MY (1) | MY175743A (enExample) |
| RU (1) | RU2014143017A (enExample) |
| SG (1) | SG11201406119WA (enExample) |
| UA (1) | UA117908C2 (enExample) |
| WO (1) | WO2013147689A1 (enExample) |
| ZA (1) | ZA201406901B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| SMT201800143T1 (it) | 2011-12-19 | 2018-05-02 | Dilafor Ab | Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico |
| CA2868403A1 (en) * | 2012-05-08 | 2013-11-14 | Dilafor Ab | Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent |
| KR20220142508A (ko) * | 2020-02-17 | 2022-10-21 | 딜라포 아베 | 자간전증 치료용 타폭시파린 |
| CA3255831A1 (en) | 2022-05-03 | 2023-11-09 | Dilafor Ab | NEW MEDICAL USE OF TAFOXIPARIN |
| EP4272749A1 (en) | 2022-05-03 | 2023-11-08 | Dilafor AB | New medical use of tafoxiparin |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2614026B1 (fr) * | 1987-04-16 | 1992-04-17 | Sanofi Sa | Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques |
| US5744457A (en) * | 1995-03-31 | 1998-04-28 | Hamilton Civic Hospitals Research Development Inc. | Compositions and methods for inhibiting thrombogenesis |
| US5993810A (en) * | 1996-03-15 | 1999-11-30 | Lebovitz; Shamir Israel | Method of softening or ripening the cervix of a female mammal using collagenase |
| SE521676C2 (sv) * | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
| US8445436B2 (en) * | 2007-12-03 | 2013-05-21 | Florida State University Research Foundation, Inc. | Oxytocin and melatonin compositions and associated methods for inducing labor |
| KR20140097380A (ko) * | 2011-11-28 | 2014-08-06 | 코닝 인코포레이티드 | 평면 투명 시트를 사용한，강력한 광학 터치 스크린 시스템 및 방법 |
| SMT201800143T1 (it) * | 2011-12-19 | 2018-05-02 | Dilafor Ab | Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico |
-
2013
- 2013-03-25 US US14/387,936 patent/US20150045322A1/en not_active Abandoned
- 2013-03-25 MY MYPI2014002745A patent/MY175743A/en unknown
- 2013-03-25 WO PCT/SE2013/050332 patent/WO2013147689A1/en not_active Ceased
- 2013-03-25 JP JP2015503158A patent/JP6234989B2/ja active Active
- 2013-03-25 EP EP13770213.0A patent/EP2830635A4/en not_active Withdrawn
- 2013-03-25 MX MX2014011505A patent/MX2014011505A/es unknown
- 2013-03-25 AU AU2013240597A patent/AU2013240597A1/en not_active Abandoned
- 2013-03-25 HK HK15103908.8A patent/HK1203369A1/xx unknown
- 2013-03-25 SG SG11201406119WA patent/SG11201406119WA/en unknown
- 2013-03-25 CN CN201380016550.6A patent/CN104203256B/zh active Active
- 2013-03-25 RU RU2014143017A patent/RU2014143017A/ru not_active Application Discontinuation
- 2013-03-25 UA UAA201411546A patent/UA117908C2/uk unknown
- 2013-03-25 CA CA2868444A patent/CA2868444A1/en not_active Abandoned
-
2014
- 2014-09-16 ZA ZA2014/06901A patent/ZA201406901B/en unknown
- 2014-09-16 IL IL234689A patent/IL234689A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013147689A1 (en) | 2013-10-03 |
| US20150045322A1 (en) | 2015-02-12 |
| SG11201406119WA (en) | 2014-11-27 |
| MY175743A (en) | 2020-07-07 |
| AU2013240597A1 (en) | 2014-10-16 |
| IL234689A0 (en) | 2014-11-30 |
| ZA201406901B (en) | 2017-09-27 |
| HK1203369A1 (en) | 2015-10-30 |
| CA2868444A1 (en) | 2013-10-03 |
| JP6234989B2 (ja) | 2017-11-22 |
| CN104203256B (zh) | 2017-11-24 |
| EP2830635A4 (en) | 2016-03-16 |
| JP2015511664A (ja) | 2015-04-20 |
| EP2830635A1 (en) | 2015-02-04 |
| MX2014011505A (es) | 2014-12-05 |
| CN104203256A (zh) | 2014-12-10 |
| RU2014143017A (ru) | 2016-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201517215D0 (en) | Use of cannabinoids in the treatment of inflammatory skin diseases | |
| IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
| EA201500314A1 (ru) | Лекарственные формы энзалутамида | |
| MX2019011825A (es) | Tratamiento de enfermedades inflamatorias con inhibidores de actividad de c5a. | |
| PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| NZ630805A (en) | Pharmaceutical combinations comprising a thionucleotide analog | |
| PH12016501139B1 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| SG11201602070TA (en) | Substituted nicotinimide inhibitors of btk and their preparation and use in the treatment of cancer, inflammation and autoimmune disease | |
| EA201590115A8 (ru) | Внеклеточная днк в качестве терапевтической мишени для бесплодия у особи женского пола и диагностического маркера | |
| IL237592B (en) | Methods of expanding and assessing b cells and using expanded b cells to treat disease | |
| IL238432B (en) | Methods and devices for the treatment of eye diseases in humans | |
| HUE040044T2 (hu) | Fumarátok prodrugjai, és azok alkalmazása különbözõ betegségek kezelésében | |
| MY185108A (en) | Method for treatment of labor arrest | |
| IL249580A0 (en) | Methods for anesthetizing nerve tissue in the trigeminal nerve pathway and their medical uses | |
| MY175743A (en) | Combination treatment comprising sulphated glycosaminoglycans for inducing labor | |
| HUE037673T2 (hu) | Szulfonil-piperidin-származékok és alkalmazásuk prokineticin-mediált betegségek kezelésére | |
| IL245738A0 (en) | Oxindole derivatives, ways of their preparation and their therapeutic use in the treatment of ampk-related diseases | |
| PH12015500663A1 (en) | Pharmaceutical combinations comprising dual angiopoietin-2/dll4 binders and anti-vegf-r agents | |
| NZ729181A (en) | Treatment of disease with poly-n-acetylglucosamine nanofibers | |
| HUE037004T2 (hu) | Szterolszármazékok és felhasználásuk transzformált asztrocitasejtekkel kapcsolatos betegségek vagy malignus hemopátiák kezelésére | |
| IN2014MN02461A (enExample) | ||
| MY192330A (en) | Treatment of postpartum haemorrhage with chemically modified heapin or heparan sulphate and a uterotonic agent | |
| PT3160437T (pt) | Composição adequada para preservar a condição fisiológica da pele e do cabelo e restabelecer as suas funções regenerativas | |
| TN2014000484A1 (en) | Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis. | |
| EP2827951A4 (en) | COMBINATION THERAPY TO IMPROVE THE HEALING OF JOINTS, TIGHTS AND TAPES |